Press & News
The next generation biopharmaceuticals
Press releases 2011
2011-09-09
Older press releases
2011-08-09
2011-05-05
2011-05-04
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q2 (August 23, 2018)